Table 3.
Best Choice of Screening Tool in Oncology (in order of preference: 1=1st place etc.) Subgroup analysis of the SIOG affiliated group is presented in italics. Please note that consensus was defined as an IQR of 2 for rounds 2 and 3, and 1 for Round 4 (as only 3 items presented to participants in final round).
| Screening Tool | Median | Mode | Interquartile Range | Consensus (R4 All:W=0.002, 2df, p=0.957;R4 SIOG:W=0.016, 2df, p=0.779) | |
|---|---|---|---|---|---|
| 1. aCGA | R2 (All): | 3.00 | 1.00 | {1.00, 7.00} | No |
| R2 (SIOG): | 2.50 | 1.00 | {1.00, 4.50} | No | |
| R3 (All): | 3.00 | 1.00 | {1.00, 4.50} | No | |
| R3 (SIOG): | 3.00 | 1.00 | {1.50, 6.00} | No | |
| R4 (All): | 2.00 | 1.00 | {1.00, 3.00} | No | |
| R4 (SIOG): | 2.00 | 2.00 | {1.00, 3.00} | No | |
|
| |||||
| 2. G8 | R2 (All): | 3.00 | 1.00 | {1.00, 5.00} | No |
| R2 (SIOG): | 2.00 | 1.00 | {1.00, 3.00} | Yes | |
| R3 (All): | 2.00 | 1.00 | {1.00, 4.00} | No | |
| R3 (SIOG): | 2.00 | 1.00 | {1.00, 3.00} | Yes | |
| R4 (All): | 2.00 | 1.00 | {1.00, 3.00} | No | |
| R4 (SIOG): | 1.50 | 1.00 | {1.00, 3.00} | No | |
|
| |||||
| 3. VES-13 | R2 (All): | 3.00 | 2.00 | {2.00, 4.00} | No |
| R2 (SIOG): | 2.50 | 2.00 | {2.00, 4.00} | No | |
| R3 (All): | 2.00 | 2.00 | {1.75, 3.25} | No | |
| R3 (SIOG): | 2.00 | 2.00 | {2.00, 3.00} | Yes | |
| R4 (All): | 2.00 | 2.00 | {1.00, 3.00} | No | |
| R4 (SIOG): | 2.00 | 2.00 | {2.00, 3.00} | Yes | |
|
| |||||
| Others under consideration | Groningen Frailty Indicator (GFI), functional status, objective physical performance (OPP), self-rated health, ECOG performance status, Karnofsky performance status, Cancer and Aging Research Group (CARG), Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH), self-rated health | ||||